The Johnson & Johnson has launched the Advancing Intratumoral Treatments QuickFire Challenge: Korea & Beyond to invite global innovators interested in leveraging the Korea ecosystem to submit differentiated solutions that advance image-guided intratumoral interventions and create new therapeutic opportunities for patients with solid tumors. The challenge seeks innovative intratumoral treatment approaches that support the Kill
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: